Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical…
| Price | $88.97 |
|---|---|
| Market cap | $15.41B |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NYSE |
| 52-week range | 62.38-94.16 |
| Beta | 0.69 |
Explore SOLV's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.